Studies show Yaz, Yasmin cause more blood clots
The U.S. Food and Drug Administration (FDA) and Health Canada have announced they are reviewing studies on the health risks associated with the birth control pills Yaz and Yasmin, as well as their generic equivalents. An early review of studies comparing oral contraceptives with the hormone drospirenone, such as Yaz and Yasmin, with pills containing another type of progestin, show that drospirenone-containing pills increase women’s risk for blood clots. The studies were published in a recent issue of the British Medical Journal.
